Genmab — Maj 2017
-
Fra webcast: Darzalex act directly on Myeloma cells and as broad immunologic activity Peter Leibowitz has completed a Phase 2 study with progression free survival and M Protein depletion as endpoint. These data currently embargoed will be presentented at a major meeting later this year
-
Det var om smoldering myeloma. Måske denne ?
https://clinicaltrials.gov/ct2/show/NCT02316106 -
-
-
det er helt sygt
-
Og mht debatten igår så var jj's udmelding om bedst af 4-5 drugs med min 4 mia en dejlig bekræftelse af de der har forventninger i den høje ende. JJ er naturligvis konservativ i den udmelding akkurat som Genmab. Langt over konsensus. Ærgerligt at debatten her på sitet tog en forkert retning en overgang
-
God morgen.
-
Enig Darvin.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind